25
Sep
2019
MERECA Q&A – Swedish
Vilka är de viktigaste resultaten och slutsatserna från MERECA-studien? Top-line data vad gäller överlevnad visar att en… Read more
News
25
Sep
2019
Webcast Link & Presentation Slides
Link to Webcast Video: https://youtu.be/IqCK8UPW44o Link to Webcast Presentation Slides: 20190925_Webcast Presentation Slides
25
Sep
2019
MERECA Q&A – English
What are the main findings and conclusions from the MERECA study? The topline data on survival benefit… Read more
25
Sep
2019
MERECA Survival Plots – Swedish
Graferna nedan detaljerar informationen om överlevnadsstatus för alla patienter i respektive studiearm (56 i ilixadencel-gruppen och 30 i… Read more
25
Sep
2019
MERECA Survival Plots – English
The graphs included below provide details on the survival status of all patients in each study arm (56… Read more
4
Sep
2019
Video Interviews on MERECA Phase II Data
Immunicum CEO, Carlos de Sousa, explains the details behind the top-line Phase II MERECA data in the… Read more
29
Aug
2019
Information on MERECA
Click below to access the full press release: Immunicum AB (publ) Announces Positive Phase II MERECA Topline… Read more
21
Aug
2019
Quarterly Report Presentation & Business Strategy video & slides
Quarterly Report Presentation & Business Strategy video – 20 Aug 2019 Quarterly Report Presentation & Business Strategy slides… Read more
20
Aug
2019
Corporate Update Event video
Click here to access the Corporate Update Event video: Quarterly Report Presentation & Business Strategy video – 20… Read more
9
Jul
2019
Cell & Gene Therapy Insights 2019 – Abstract
Click here to access the abstract published in Cell & Gene Therapy Insights The advantage of allogenicity when… Read more
